Giovannoni G, et al. Cladribine tablets in high disease activity (HDA) subgroups from the CLARITY study of patients with relapsing multiple sclerosis (RMS). EP1157. EAN 2017.
Neurodegeneratieve en psychiatrische aandoeningen in ALS-families
jul 2017 | Neuro-musculair